University of Leicester
Browse
1-s2.0-S0085253818308093-main.pdf (1.8 MB)

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Download (1.8 MB)
journal contribution
posted on 2019-08-28, 10:25 authored by J Floege, SJ Barbour, DC Cattran, JJ Hogan, PH Nachman, SCW Tang, JFM Wetzels, M Cheung, DC Wheeler, WC Winkelmayer, BH Rovin, Conference Participants
The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

Funding

The conference was sponsored by KDIGO and supported in part by unrestricted educational grants from Achillion, Aurinia Pharmaceuticals, Calliditas Therapeutics, ChemoCentryx, Chugai, Expedition Therapeutics, Gilead, Goldfinch Bio, Kyowa Kirin, Mallinckrodt Pharmaceuticals, Novartis, Omeros, Sanofi Genzyme, and Vifor Fresenius Medical Care Renal Pharma.

History

Citation

Kidney International, 2019, 95 (2), pp. 268-280

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Infection, Immunity and Inflammation

Version

  • VoR (Version of Record)

Published in

Kidney International

Publisher

Elsevier for International Society of Nephrology

eissn

1523-1755

Acceptance date

2018-10-24

Copyright date

2019

Available date

2019-08-28

Publisher version

https://www.sciencedirect.com/science/article/pii/S0085253818308093?via=ihub

Notes

SUPPLEMENTARY MATERIAL Table S1. 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis (GN) guideline recommendations related to IgA nephropathy: Need to be revisited? Table S2. 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis (GN) guideline recommendations related to membranous nephropathy (MN): Need to be revisited? Supplementary material is linked to the online version of the paper at www.kidney-international.org.

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC